Patent applications published 7 April 2010
Patent applications taken from the weekly European Patents Bulletin
- Combination tablet with chewable outer layer
Habboushe, Joseph Peter 2170051*
- Compsns and methods of use of phorbol esters
Biosuccess Biotech 2170053*
- Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
Capsutech 2170054*
- Compsn and method for treating connective tissue damage
Arthrodynamic Technologies 2170055*
- Single dose roxithromycin
IDEXX Laboratories 2170056*
- 5’-substituted adenosynes, preparation thereof and use as inhibitors of S-adenosylmethionine decarboxylase
Southern Research Institute; Cornell University; The Penn State Research Foundation; R Lee Moffitt Cancer Centre and Research Institute 2170057*
- CETP inhibitors derived from benzoxazole arylamides
Merck Sharp & Dohme 2170058*
- CETP inhibitors derived from benzoxazole arylamides
Merck Sharp & Dohme 2170059*
- Alpha-chloro and alpha-bromo phosphonate analogues of lysophosphatidic acid and methods of making and using thereof
University of Utah Research Foundation; University of Tennessee Research Foundation 2170060*
- Substituted pyrrolidine compounds with central nervous system activity
The Research Foundation of State University of New York 2170061*
- Methods and compsns for the treatment of cancer, tumours, and tumour-related disorders
Tragara Pharmaceuticals 2170062*
- Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
Teikoku Pharma 2170063*
- 6.5-pyrrolopiperidine tachykinin receptor antagonists
Merck Sharp & Dohme 2170064*
- Diphenyl substituted alkanes
Merck Sharp & Dohme 2170065*
- Liquiritigenin and derivatives as selective oestrogen receptor beta agonists
Bionovo 2170067*
- Farnesoid X receptor agonists
GlaxoSmithKline 2170072*
- Selective inhibitors for cyclin-dependent kinases
Emory University; Imperial College of Science and Technology 2170073*
- Labelled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
The Johns Hopkins University 2170075*
- 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
Merck Sharp & Dohme 2170076*
- Process for the preparation of malathion and its intermediate
Suven Life Sciences 2170078*
- Cationic peptide for delivering an agent into a cell
Agency for Science, Technology and Research 2170267*
- Compsns of specific binding agents to hepatocyte growth factor
Amgen 2170268*
- Article comprising calcium for reducing the production of TSST-1
Procter & Gamble 2170269*
- Compsns for delivering medicaments into the lungs, uses thereof
Paka Pulmonary Pharmaceuticals 2170270*
- Locally administered low doses of corticosteroids
Warsaw Orthopaedic 2170271*
- Pharmaceutical formulation for the production of rapidly disintegrating tablets
BASF 2170273*
- Compsns, articles and methods comprising TSPO ligands for preventing or reducing tobacco-associated damage
Technion Research & Development Foundation 2170274*
- Dual portion lozenge dosage form
McNeil-PPC 2170275*
- Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
Warner Chilcott 2170276*
- Chemical modification of maleated fatty acids
Georgia-Pacific Chemicals 2170277*
- Formulations of N-(2-acetyl-4,6-dimethylphenyl)-3-{Y(3,4 dimethyl-5-isoxazoyl)amino]sulphonyl}-2-thiophenecarboxamide
Encysive Pharmaceuticals 2170278*
- Methods for producing aripiprazole suspension and freeze-dried formulation
Otsuka Pharmaceutical 2170279*
- An inhalable compsn containing nicotine
Kind Consumer 2170280*
- Method for the production of a medicament containing tadalafanil
Ratiopharm 2170281*
- Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
Hanmi Pharm 2170282*
- Formation of stable submicron peptide or protein particles by thin film freezing
Board of Regents, The University of Texas System 2170283*
- A method of preparing a pharmaceutical co-crystal compsn
Feyecon Development and Implementation 2170284*
- Process for the preparation of controlled-release solid formulations containing oxcarnazepine, and formulations obtainable by said process
Archimica 2170285*
- Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
ADD Advanced Drug Delivery Technologies 2170288*
- Preparation method for solid dispersions
Formac Pharmaceuticals 2170289*
- System for controlled release of an active principle and method for preparation
Centre National de la Recherche Scientifique; Université Montpellier 2170290*
- Pharmaceutical compsn containing acetylcholine esterase inhibitor and method for the preparation thereof
Genepharm 2170291*
- Tableted compsns containing atazanavir
Bristol-Myers Squibb 2170292*
- Combination formulations comprising darunavir and etravirine
Tibotec Pharmaceuticals 2170293*
- Improved pharmaceutical formulation containing an HMG-CoA reductase inhibitor and method for the preparation thereof
Pharmathen 2170294*
- Improved pharmaceutical compsn containing dihydropyridine calcium channel antagonist and method for the preparation thereof
Pharmathen; Recordati Ireland 2170295*
- Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate
Ratiopharm 2170296*
- Duloxetine formulation
Arrow International 2170297*
- Hard gelatin capsule formulation comprising a pumpkin product
GlaxoSmithKline Consumer Healthcare 2170298*
- A novel powder and its method of manufacture
NANO4M 2170299*
- Microstructures having core-shell structure
Otsuka Pharmaceutical 2170300*
- Virus-modified bacteria ghosts
Lubitz, Werner 2170301*
- Sustained release bionanocomposites, a process for producing the same and use thereof
Szegedi Tudomanyegyetem 2170302*
- A bioerodible patch
Drug Delivery Solutions 2170304*
- Transdermal drug delivery system comprising glycopyrrolate to treat sialorrhea
Sciele Pharma 2170305*
- Methods of treating serotonin-mediated diseases and disorders
Lexicon Pharmaceuticals 2170306*
- Endoparasiticidal topical compsns
Wyeth 2170308*
- Methods and compsns for treating disorders
Hydra Biosciences 2170309*
- Quick dissolve compsns of memantine hydrochloride
Orchid Chemicals and Pharmaceuticals 2170310*
- Compounds and methods for treating or preventing autoimmune diseases
Avalon Pharmaceuticals; Medimmune 2170311*